Company: SUPN
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001356576-25-000055
Chunk: 118

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part II, Item 6
Chunk 118
---
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.SUPERNUS PHARMACEUTICALS, INC.DATED: August 5, 2025By:/s/ Jack A. KhattarJack A. KhattarPresident and Chief Executive OfficerDATED: August 5, 2025By:/s/ Timothy C. DecTimothy C. DecSenior Vice-President and Chief Financial Officer

45